aTyr Pharma to Present at the 36th Annual J.P. Morgan Healthcare Conference
January 04 2018 - 8:00AM
aTyr Pharma, Inc. (Nasdaq:LIFE), a biotherapeutics company engaged
in the discovery and development of innovative medicines based on
novel immunological pathways, today announced that Sanjay Shukla,
M.D., M.S., President and Chief Executive Officer, will present at
the 36th Annual J.P. Morgan Healthcare Conference on Thursday,
January 11, 2018 at 8:00 a.m. Pacific Time. The conference will be
held at the Westin St. Francis in San Francisco, CA.
Links to a live audio webcast and replay of the presentation may
be accessed on the aTyr website events page at:
http://investors.atyrpharma.com/events-and-webcasts. An audio
replay will be available for 90 days following the event.
About aTyr Pharma
aTyr Pharma is engaged in the discovery and development of
innovative medicines using its knowledge of newly discovered
pathways in immunology effected by extracellular tRNA synthetases.
To date, aTyr has generated three innovative and unique development
programs based on its knowledge of extracellular histidyl-tRNA
synthetase (HARS), known as the Resokine pathway. aTyr’s two
clinical-stage programs, ATYR1940 (Resolaris) and ATYR1923
(iMod.Fc), are agonists of the Resokine pathway designed to temper
immune engagement in diseases characterized by excessive immune
cell involvement in muscle and lung. aTyr’s third program, ORCA,
represents a pre-clinical research program that targets a novel,
proprietary immuno-oncology pathway using antibodies to enhance the
immune response in tumor settings. aTyr has built an intellectual
property estate, to protect its pipeline, comprising over 220
issued patents or allowed patent applications that are owned or
exclusively licensed, including over 300 potential protein
compositions derived from tRNA synthetase genes. For more
information, please visit http://www.atyrpharma.com.
Contact:Mark Johnson Sr. Director, Investor
Relationsmjohnson@atyrpharma.com858-223-1163
aTyr Pharma (NASDAQ:LIFE)
Historical Stock Chart
From Mar 2024 to Apr 2024
aTyr Pharma (NASDAQ:LIFE)
Historical Stock Chart
From Apr 2023 to Apr 2024